Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2759 | IKK16 | 2.0 | uM | 1 | IL-13 | 13.0 | 69 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL-13 | 13.0 | 49 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | IL-13 | 15.0 | 60 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL-13 | 13.0 | 50 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | IL-13 | 13.0 | 67 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | IL-13 | 13.0 | 49 | ||||
| RA1869 | 1 | IL-13 | 13.0 | 51 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | IL-13 | 13.0 | 39 | ||||
| N2759 | 1 | IL-13 | 15.0 | 54 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | IL-13 | 14.0 | 51 | ||||
| RA1931 | 1 | IL-13 | 16.0 | 63 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | IL-13 | 19.0 | 47 | ||||
| N2586 | 1 | IL-13 | 18.0 | 75 | |||||||
| 0 | IL-13 | 13.5 | 56 | ||||||||
| 0 | IL-13 | 12.0 | 65 | ||||||||
| 0 | IL-13 | 12.0 | 65 | ||||||||
| 0 | IL-13 | 12.0 | 71 | ||||||||
| 0 | IL-13 | 10.5 | 42 | ||||||||
| 0 | IL-13 | 14.0 | 41 | ||||||||
| RA2159 | 2 | IL-13 | 16.0 | 66 | |||||||
| N2645 | 2 | IL-13 | 24.0 | 66 | |||||||
| RA2708 | 2 | IL-13 | 17.0 | 65 | |||||||
| RA2159 | JNK-IN-8 | 3.0 | uM | 2 | IL-13 | 15.0 | 73 | ||||
| RA2159 | PH-797804 | 0.6 | uM | 2 | IL-13 | 16.5 | 74 | ||||
| N2645 | JNK-IN-8 | 3.0 | uM | 2 | IL-13 | 17.0 | 64 |